癌症突变汇聚于一组蛋白组装体以预测复制应激抵抗
研究开发了一组预测模型,利用深度学习阐明癌症突变如何影响对常见复制应激诱导药物的反应。在肿瘤细胞中鉴定出41个分子组装体,整合数百个基因改变以准确预测药物反应,其中30个经功能缺失遗传筛选显示可调节药物敏感性或复制重启。模型可转化至顺铂治疗的宫颈癌患者,揭示RTK-JAK-STAT组装体调控耐药。
要点
- 41个分子组装体整合数百基因改变,可准确预测药物反应。
- 30个组装体经功能缺失筛选显示调节药物敏感性或复制重启。
- 模型在顺铂治疗的宫颈癌患者中揭示RTK-JAK-STAT组装体调控耐药。
核心结论
- 研究定义了一组突变影响治疗反应的机制汇编,对精准医学具有意义。
研究设计与样本
- 研究开发了一组预测模型,利用深度学习实现多药预测和机制解释。
- 初始研究在肿瘤细胞中进行,鉴定出41个分子组装体。
- 模型转化至顺铂治疗的宫颈癌患者。
主要发现
- 41个分子组装体整合数百个基因改变,可准确预测药物反应。
- 这些组装体涵盖转录、修复、细胞周期检查点和生长信号传导中的作用。
- 其中30个组装体经功能缺失遗传筛选显示可调节药物敏感性或复制重启。
- 模型在顺铂治疗的宫颈癌患者中突出显示一个调控耐药的RTK-JAK-STAT组装体。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Rapid proliferation is a hallmark of cancer associated with sensitivity to therapeutics that cause DNA replication stress (RS). Many tumors exhibit drug resistance, however, via molecular pathways that are incompletely understood. Here, we develop an ensemble of predictive models that elucidate how cancer mutations impact the response to common RS-inducing (RSi) agents. The models implement recent advances in deep learning to facilitate multidrug prediction and mechanistic interpretation. Initial studies in tumor cells identify 41 molecular assemblies that integrate alterations in hundreds of genes for accurate drug response prediction. These cover roles in transcription, repair, cell-cycle checkpoints, and growth signaling, of which 30 are shown by loss-of-function genetic screens to regulate drug sensitivity or replication restart. The model translates to cisplatin-treated cervical cancer patients, highlighting an RTK-JAK-STAT assembly governing resistance. This study defines a compendium of mechanisms by which mutations affect therapeutic responses, with implications for precision medicine. SIGNIFICANCE: Zhao and colleagues use recent advances in machine learning to study the effects of tumor mutations on the response to common therapeutics that cause RS. The resulting predictive models integrate numerous genetic alterations distributed across a constellation of molecular assemblies, facilitating a quantitative and interpretable assessment of drug response. This article is featured in Selected Articles from This Issue, p. 384.
引用
- Zhao X, Singhal A, Park S, et al. Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress. Cancer Discov. 2024. PMID: 38236062. doi:10.1158/2159-8290.CD-23-0641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。